Palvella Therapeutics Q2 EPS $(1.52) Misses $(1.14) Estimate

Palvella Therapeutics (NASDAQ:PVLA) reported quarterly losses of $(1.52) per share which missed the analyst consensus estimate of $(1.14) by 33.33 percent. This is a 76.74 percent decrease over losses of $(0.86) per share from the same period last year.